← Back to Search

Prehabilitation Program for Multiple Myeloma

N/A

Recruiting

Research Sponsored by Smith Giri

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Scheduled for ASCT at UAB within 10 weeks of study enrollment

Diagnosis of Multiple Myeloma

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial tests if a prehabilitation program before stem cell transplant can improve physical function in older adults.

Who is the study for?

This trial is for individuals aged 60 or older who have been diagnosed with Multiple Myeloma and are scheduled to undergo Autologous Stem Cell Transplantation (ASCT) at UAB within the next 10 weeks. Those at high risk for imminent bone fractures as determined by Mirels score cannot participate.Check my eligibility

What is being tested?

The study is testing a prehabilitation program consisting of a multi-modal exercise regimen and dietary guidelines against an attention control group, to see if it's feasible and how it affects physical function before transplant and after 12 weeks.See study design

What are the potential side effects?

Since this trial involves exercise and dietary changes rather than medication, side effects may include muscle soreness, fatigue from increased activity, or potential nutritional deficiencies if not followed properly.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am scheduled for a stem cell transplant at UAB within 10 weeks of joining the study.

Select...

I have been diagnosed with Multiple Myeloma.

Select...

I am 60 years old or older and have had a stem cell transplant.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability

Adherence rate

Completion rate

+1 more

Secondary outcome measures

Change in Functional Exercise Capacity

Change in Lower Extremity Physical Function

Change in functional status

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: TeleprehabExperimental Treatment2 Interventions

The participants selected for the teleprehab arm will undergo a supervised 8-week multi-modal exercise program in a telehealth format (using doxy.me, a free telehealth platform) delivered by licensed physical or occupational therapists who have undergone cancer specific rehabilitation training within Select Medical's ReVital® cancer rehabilitation program. Participants will attend teleprehab sessions 2 times per week for a total of 16 sessions.

Group II: Attention ControlExperimental Treatment1 Intervention

The participants randomized to the attention control arm will not undergo an exercise regimen, but will be contacted by the study staff on the phone once a week..

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Smith GiriLead Sponsor

Media Library

Dietary Guidelines Clinical Trial Eligibility Overview. Trial Name: NCT05642884 — N/A

Multiple Myeloma Research Study Groups: Teleprehab, Attention Control

Multiple Myeloma Clinical Trial 2023: Dietary Guidelines Highlights & Side Effects. Trial Name: NCT05642884 — N/A

Dietary Guidelines 2023 Treatment Timeline for Medical Study. Trial Name: NCT05642884 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies still available for participants in this trial?

"Clinicaltrials.gov states that this particular trial is not presently enrolling patients, despite its initial posting on January 1st 2023 and recent update of November 29th 2022. At the moment, 810 other studies across various disciplines are actively recruiting participants."

Answered by AI

What are the end objectives of this experimental endeavor?

"The primary aim of this year-long supervised clinical trial is to track completion rate. Secondary goals include tracking changes in daily life activities, lower body physical function, and functional exercise capacity via the Older Americans Resources and Services (OARS) Activities of Daily Living and Instrumental Activities of Daily Living (ADL/IADL), Short Physical Performance Battery Scores (SPPB), as well as 6-minute walking distance (6MWD)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Prehabilitation Feasibility Among Older Adults Undergoing Transplantation

Smith Giri 2023. "Prehabilitation Feasibility Among Older Adults Undergoing Transplantation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05642884.